Pharmacogenomics at the Point of Care: A Community Pharmacy Project in British Columbia.

Reports offered three prescribing considerations: ‘usual—normal label use of compound’; ‘minor- consider test results, as results may be significant’; and ‘major—significant results, medication should be reviewed’.

also in 13,097 other papers